Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramalingam

Showing results (341-350 of 502) with videos related to

Pageof 51
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2021
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 TrialConor E Steuer, Opeyemi A Jegede, Suzanne E Dahlberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignanciesSuresh S Ramalingam, Merrill J Egorin, Ramesh K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignanciesSuresh S Ramalingam, Robert A Parise, Ramesh K Ramanathan, et al.
Nature Biomedical Engineering|October 31, 2024
Spatially resolved subcellular protein-protein interactomics in drug-perturbed lung-cancer cultures and tissuesShuangyi Cai, Thomas Hu, Abhijeet Venkataraman, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancerJunghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2015
Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanibEvelyn M McKeegan, Peter J Ansell, Gerard Davis, et al.
British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
Clinical Lung Cancer|June 12, 2017
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database AnalysisHiba Z Ahmed, Yuan Liu, Kelli O'Connell, et al.
Oral Oncology|April 14, 2015
Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysisLindsay J Joseph, Michael Goodman, Kristin Higgins, et al.
Pageof 51

Showing results (341-350 of 502) with videos related to

Sort By:
Pageof 51
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2021
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 TrialConor E Steuer, Opeyemi A Jegede, Suzanne E Dahlberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignanciesSuresh S Ramalingam, Merrill J Egorin, Ramesh K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignanciesSuresh S Ramalingam, Robert A Parise, Ramesh K Ramanathan, et al.
Nature Biomedical Engineering|October 31, 2024
Spatially resolved subcellular protein-protein interactomics in drug-perturbed lung-cancer cultures and tissuesShuangyi Cai, Thomas Hu, Abhijeet Venkataraman, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancerJunghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2015
Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanibEvelyn M McKeegan, Peter J Ansell, Gerard Davis, et al.
British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
Clinical Lung Cancer|June 12, 2017
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database AnalysisHiba Z Ahmed, Yuan Liu, Kelli O'Connell, et al.
Oral Oncology|April 14, 2015
Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysisLindsay J Joseph, Michael Goodman, Kristin Higgins, et al.
Pageof 51